Skip to content

NBA G-League Sweat Testing Study: Validity of the Gx Sweat Patch in Measuring Sweating Rate and Sweat Chloride Concentration During On-court Training With Basketball Players

NBA G-League Sweat Testing Study: Validity of the Gx Sweat Patch in Measuring Sweating Rate and Sweat Chloride Concentration During On-court Training With Basketball Players

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04679532
Enrollment
65
Registered
2020-12-22
Start date
2020-12-08
Completion date
2021-11-04
Last updated
2022-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sweat Analysis

Keywords

sweating rate, sweat electrolytes, sweat electrolyte concentration, sweat patch, wearable, epidermal, Gx patch

Brief summary

To determine the validity of the Gx Sweat Patch in measuring sweating rate and sweat chloride concentration during moderate-high intensity practice against well-established reference methods in field conditions with basketball athletes

Interventions

OTHERGx sweat patch

Adhesive-backed flexible epidermal wearable regional sweat patch to collect and analyze sweat via microfluidics and colorimetric assay

OTHERReference sweat patch

Adhesive Tegaderm with absorbent pad regional sweat patch to collect sweat, followed by standard benchtop gravimetry and ion chromatography methods to analyze sweat

Sponsors

PepsiCo Global R&D
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

Each subject serves as their own control. Both devices are worn during the same exercise session.

Eligibility

Sex/Gender
MALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* 18-40 years of age * Subject is participating in training/competition with the NBA G-league * Subject is participating in a coach led practice

Exclusion criteria

* Subject has an allergy to adhesives (e.g., experiences rash reactions to typical adhesive bandages) * Subject has participated in a clinical trial within past 30 days * Subject has participated in any PepsiCo trial within past 6 months * Subject has a condition the investigator believes would interfere with his/her ability to provide informed consent, comply with the study protocol, which might confound the interpretation of the study results or put the person at undue risk

Design outcomes

Primary

MeasureTime frameDescription
Regional sweat chloride concentrationAverage across a single practice session on 1 dayGx patch vs. reference patch during exercise. Gx patch analyzed by colorimetry via smartphone app. Reference patch analyzed with ion chromatography

Secondary

MeasureTime frameDescription
Regional sweating rateAverage across the same single practice session on the same 1 day as the primary outcomeGx patch vs. reference patch during exercise. Gx patch analyzed by microfluidic reading with Smartphone. Reference patch analyzed with gravimetry
Whole body sweating rateMeasured one time to represent the average across the same single practice session on the same 1 day as the primary outcomeChange in body mass from pre- to post-exercise, corrected for fluid/food intake and urine loss. Body mass measured to the nearest 0.01 kg using a digital platform scale

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026